Manufacturing feasibility assessment
5. Verdict
Use a conventional solid or roll-on deodorant with playful compact packaging, region-specific cosmetic compliance, and validated skin safety; start with a 1,000-unit pilot.
6. Subsystems
- 6.1 Non-aerosol deodorant formatMEDIUM
- 6.2 Cosmetic formulaMEDIUM
- 6.3 Miniature primary packMEDIUM
- 6.4 Filling and assemblyLOW
- 6.5 Claims and artworkMEDIUM
- 6.6 Global market releaseMEDIUM
7. Bill of materials
| Item | 100 | 1,000 | 10,000 |
|---|---|---|---|
| 7.1 Deodorant base and odor-control ingredients, 15–25 g | $0.55–0.95 | $0.30–0.55 | $0.18–0.35 |
| 7.2 Fragrance, color, and cosmetic additives | $0.18–0.35 | $0.10–0.22 | $0.06–0.14 |
| 7.3 Stock mini twist-up or roll-on primary pack | $0.95–1.60 | $0.55–0.95 | $0.32–0.62 |
| 7.4 Label or direct pack decoration | $0.28–0.55 | $0.14–0.30 | $0.07–0.16 |
| 7.5 Paperboard carton and insert | $0.30–0.58 | $0.17–0.32 | $0.10–0.20 |
| 7.6 Contract filling, assembly, and batch coding | $0.75–1.35 | $0.38–0.72 | $0.22–0.45 |
| 7.7 QA release, scrap allowance, and shipper allocation | $0.32–0.62 | $0.18–0.34 | $0.12–0.25 |
| 7.8 Estimated ex-factory BOM and conversion | $3.33–6.00 | $1.82–3.40 | $1.07–2.17 |
At 10k units, stock-pack setup adds about $0.10–0.40/unit (1–5% of $8 retail). Custom tooling adds $2.50–6.00/unit (31–75% of $8 retail), so it is not supportable at launch.
8. Gates to clear
8.1 [DFM]
The concept must change from an unspecified “micro fun” pack to a defined stock 15–25 g stick or roll-on with a fillable formula and controlled tolerances.
Path: Select two stock mini-pack samples from cosmetic packaging distributors, run formula/pack compatibility at a deodorant contract filler, then lock fill weight, label zone, carton, and drop-test criteria.
8.2 [Certification]
Global cosmetic sale is not one approval. Formula, claims, allergens, safety file, labels, and local responsible-party requirements must be controlled by market.
Path: Start with cosmetic odor-control claims; complete safety assessment and stability testing, then use regulatory consultants for US FDA/MoCRA facility-product obligations, EU Cosmetics Regulation 1223/2009 PIF/CPSR/CPNP, UK SCPN, and target-country notifications.
8.3 [Tooling]
Custom fun-shaped packaging consumes too much of an $8–15 retail price at a 10k launch volume, despite the core BOM being below the $3.20 low-price threshold.
Path: Launch in a decorated stock mini dispenser with sleeves, labels, or carton graphics; obtain custom-pack quotations only after demand supports at least 50k–100k units or a retailer funds development tooling.
9. Prototype sequence
- 9.1Write a one-page product brief defining format, 15–25 g fill, fragrance direction, target countries, and cosmetic-only claims.This converts the concept into a formulator, pack supplier, and regulatory team can quote and assess.
- 9.2Source stock mini twist-up and roll-on packs and obtain three formula bench samples from a deodorant formulator.The required change is validated early: compact fun presentation without custom molded-pack cost.
- 9.3Run pack compatibility, accelerated stability, odor-control panel screening, and microbiological testing appropriate to the chosen formula.This confirms the formula remains stable, usable, and safe in the selected pack.
- 9.4Produce a 100–300 unit pilot through a cosmetic contract filler using production-intent labels and cartons.This exposes filling, capping, labeling, batch coding, yield, and shipping issues before a 10k commitment.
- 9.5Compile market-specific artwork and safety documentation, then launch first in selected jurisdictions before wider global rollout.Staged release keeps US FDA/MoCRA, EU CPNP, UK SCPN, and local notification work manageable and compliant.
Assessment criteria: J. Tanikella · Engine: GPT-5.6 Terra.
